Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,990.00
-30.00 (-0.50%)
At close: Jun 5, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 40.85 billion as of June 5, 2026. Its market cap has increased by 0.39% in one year.
Market Cap
40.85B
Enterprise Value
29.99B
Revenue
36.27B
Ranking
n/a
PE Ratio
6.00
Stock Price
5,990.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has decreased from 47.59B to 40.85B, a decrease of -14.17%. That is a compound annual growth rate of -2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 40.85B | -13.79% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 180.84B |
| CG MedTech | 141.98B |
| Sewoon Medical | 96.54B |
| OSTEONIC | 94.99B |
| JW Shinyak | 75.65B |
| SCL Science | 63.74B |
| MEDYSSEY Co.,Ltd | 41.22B |
| KM Corporation | 34.27B |